医学
食品药品监督管理局
药品审批
药品
药理学
重症监护医学
批准的药物
标签外使用
作者
Alex M. Ebied,Hesham Elmariah,Rhonda M. Cooper‐DeHoff
标识
DOI:10.1016/j.amjmed.2023.02.019
摘要
In 2022, the US Food and Drug Administration (FDA) approved 37 novel drugs. Twenty-four of the 37 (65%) novel drug approvals were reviewed and approved through an expedited review pathway and 20 of the 37 (54%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the FDA in 2022.
科研通智能强力驱动
Strongly Powered by AbleSci AI